Literature DB >> 23632857

Function of oncogenes in cancer development: a changing paradigm.

Carolina Vicente-Dueñas1, Isabel Romero-Camarero, Cesar Cobaleda, Isidro Sánchez-García.   

Abstract

Tumour-associated oncogenes induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, therapeutic strategies that block oncogene activity are likely to selectively target tumour cells. However, recent evidences have revealed that oncogenes are only essential for the proliferation of some specific tumour cell types, but not all. Indeed, the latest studies of the interactions between the oncogene and its target cell have shown that oncogenes contribute to cancer development not only by inducing proliferation but also by developmental reprogramming of the epigenome. This provides the first evidence that tumorigenesis can be initiated by stem cell reprogramming, and uncovers a new role for oncogenes in the origin of cancer. Here we analyse these evidences and propose an updated model of oncogene function that can explain the full range of genotype-phenotype associations found in human cancer. Finally, we discuss how this vision opens new avenues for developing novel anti-cancer interventions.

Entities:  

Mesh:

Year:  2013        PMID: 23632857      PMCID: PMC3671260          DOI: 10.1038/emboj.2013.97

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  86 in total

1.  Global DNA demethylation during mouse erythropoiesis in vivo.

Authors:  Jeffrey R Shearstone; Ramona Pop; Christoph Bock; Patrick Boyle; Alexander Meissner; Merav Socolovsky
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

2.  Cancer's source in the peripheral nervous system.

Authors:  Peter B Dirks
Journal:  Nat Med       Date:  2008-04       Impact factor: 53.440

3.  Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells.

Authors:  Uri Ben-David; Yoav Mayshar; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

4.  MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

Authors:  Chi Wai So; Holger Karsunky; Emmanuelle Passegué; Antonio Cozzio; Irving L Weissman; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

5.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  Stem cells: The promises and perils of p53.

Authors:  Valery Krizhanovsky; Scott W Lowe
Journal:  Nature       Date:  2009-08-27       Impact factor: 49.962

9.  Nuclear cloning of embryonal carcinoma cells.

Authors:  Robert H Blelloch; Konrad Hochedlinger; Yasuhiro Yamada; Cameron Brennan; Minjung Kim; Beatrice Mintz; Lynda Chin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

10.  Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.

Authors:  H Zheng; H Ying; H Yan; A C Kimmelman; D J Hiller; A-J Chen; S R Perry; G Tonon; G C Chu; Z Ding; J M Stommel; K L Dunn; R Wiedemeyer; M J You; C Brennan; Y A Wang; K L Ligon; W H Wong; L Chin; R A dePinho
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-01-15
View more
  35 in total

Review 1.  Epigenetic alterations in human parathyroid tumors.

Authors:  Chiara Verdelli; Irene Forno; Valentina Vaira; Sabrina Corbetta
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

2.  Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice.

Authors:  Yunxian Liu; Leena Hilakivi-Clarke; Yukun Zhang; Xiao Wang; Yuan-Xiang Pan; Jianhua Xuan; Stefanie C Fleck; Daniel R Doerge; William G Helferich
Journal:  Mol Nutr Food Res       Date:  2015-06-26       Impact factor: 5.914

Review 3.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

4.  Loss of Pax5 Exploits Sca1-BCR-ABLp190 Susceptibility to Confer the Metabolic Shift Essential for pB-ALL.

Authors:  Alberto Martín-Lorenzo; Franziska Auer; Lai N Chan; Idoia García-Ramírez; Inés González-Herrero; Guillermo Rodríguez-Hernández; Christoph Bartenhagen; Martin Dugas; Michael Gombert; Sebastian Ginzel; Oscar Blanco; Alberto Orfao; Diego Alonso-López; Javier De Las Rivas; Maria B García-Cenador; Francisco J García-Criado; Markus Müschen; Isidro Sánchez-García; Arndt Borkhardt; Carolina Vicente-Dueñas; Julia Hauer
Journal:  Cancer Res       Date:  2018-02-28       Impact factor: 12.701

5.  Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation.

Authors:  Gian P Dagrada; Rosalin D Spagnuolo; Valentina Mauro; Elena Tamborini; Luca Cesana; Alessandro Gronchi; Silvia Stacchiotti; Marco A Pierotti; Tiziana Negri; Silvana Pilotti
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

6.  Notch signaling defects in NK cells in patients with cancer.

Authors:  Gulnur K Zakiryanova; Elena Kustova; Nataliya T Urazalieva; Emile T Baimukhametov; Valeriy A Makarov; Gulmariya M Turaly; Galina V Shurin; Zarema M Biyasheva; Narymzhan N Nakisbekov; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2020-10-21       Impact factor: 6.968

7.  Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.

Authors:  Alejandro Vazquez-Martin; Sílvia Cufí; Eugeni López-Bonet; Bruna Corominas-Faja; Elisabet Cuyàs; Luciano Vellon; Juan Manuel Iglesias; Olatz Leis; Angel G Martín; Javier A Menendez
Journal:  Cell Cycle       Date:  2013-10-04       Impact factor: 4.534

Review 8.  Cellular reprogramming in skin cancer.

Authors:  Ihn Young Song; Allan Balmain
Journal:  Semin Cancer Biol       Date:  2014-04-08       Impact factor: 15.707

9.  Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4.

Authors:  Patricia Fernandez; Paola Scaffidi; Elke Markert; Ji-Hyeon Lee; Sushil Rane; Tom Misteli
Journal:  Cell Rep       Date:  2014-10-02       Impact factor: 9.423

Review 10.  Directly targeting transcriptional dysregulation in cancer.

Authors:  Thomas J Gonda; Robert G Ramsay
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.